Ignite Creation Date:
2024-05-06 @ 11:01 AM
Last Modification Date:
2024-10-26 @ 12:39 PM
Study NCT ID:
NCT03414034
Status:
COMPLETED
Last Update Posted:
2023-11-01
First Post:
2018-01-22
Brief Title:
Onvansertib in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor:
Cardiff Oncology
Organization:
Cardiff Oncology
Organization Data
Organization:
Cardiff Oncology
Class:
INDUSTRY
Study ID:
TROV-053
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cardiff Oncology
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None